Shareholders are referred to the announcement of 8 September 2020 wherein it was confirmed that Aspen Global Incorporated, incorporated in Mauritius, a wholly owned subsidiary of Aspen Holdings, had concluded an agreement in terms whereof Mylan Ireland Limited would acquire the commercialization rights and related intellectual property in respect of Aspen's Thrombosis Business in Europe(1) for a purchase consideration of EUR 641.9 million, plus the cost of the related inventory (the 'Transaction').

Aspen is pleased to confirm that it has received confirmation that all conditions precedent requiring third party consents and approvals for the Transaction have now been fulfilled, with the remaining conditions precedent being within the control of the parties. The parties are mutually committed to closure of the Transaction on 27 November 2020.

Contact:

Tel: +27 31 580-8600

(C) 2020 Electronic News Publishing, source ENP Newswire